Rifampicin Capsule

DRUG5 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Cascade Pharmaceuticals, Inc

Conditions

Advanced Malignant NeoplasmHealthy Adult SubjectsHealthy VolunteersMyelofibrosisProstate Cancer

Phase 1

A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib

CompletedNCT04494659

Jiangsu HengRui Medicine Co., Ltd.Healthy Adult Subjects

Start: 2020-07-20End: 2020-08-31Updated: 2020-09-29

A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets

CompletedNCT06024915

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Myelofibrosis

Start: 2023-09-21End: 2024-05-06Updated: 2025-12-12

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Advanced Malignant Neoplasm

Start: 2023-12-31End: 2024-03-31Target: 40Updated: 2023-12-12

A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects

CompletedNCT07014488

Jiangsu HengRui Medicine Co., Ltd.Prostate Cancer

Start: 2025-06-20End: 2025-08-01Updated: 2025-09-10

Drug Interaction and Food Effect Study of CS0159

Not yet recruitingNCT07429331

Cascade Pharmaceuticals, IncHealthy Volunteers

Start: 2026-03-01End: 2027-02-01Target: 32Updated: 2026-02-24

Related Papers

The effect of rifampin on the pharmacokinetics of famitinib in healthy subjects

Cancer Chemotherapy and Pharmacology2022-09-153 citations